Industry veteran with proven track record in neurorehabilitation and fundraising to lead next phase of growth; Co-founder Brian Harris transitions to Chief Scientific OfficerPORTLAND, Maine, July 7, 2025 /PRNewswire/ -- MedRhythms, Inc., a company pioneering the development of next-generation neurotherapeutics to improve walking, mobility and related functional outcomes, and creator of the world's first prescription music platform, announced the appointment of Larry Jasinski as Chief Executive Officer, effe ...

Market Opportunity & Disease Burden - Heart failure affects over 6 million people in the U S [9], leading to over 1 1 million hospital discharges and over 1 3 million emergency room visits annually [11] - The annual costs associated with heart failure are expected to reach $70 billion by 2030 in the U S [11] - The U S annual net addressable market for Barostim is estimated at $2 2 billion, assuming an average selling price (ASP) of $29,000 [37] Barostim Therapy & Clinical Evidence - Barostim is presented as a neuromodulation therapy designed to improve heart failure symptoms [8] - Barostim implantation is a 60-minute procedure with a 97% freedom from major complications [46, 48] - Real-world evidence demonstrates an 85% relative reduction in hospital visits per year post-Barostim implant (average 1 92 years) compared to pre-implant (12 months) [67] Financial Performance & Guidance - Worldwide revenue for 2024 was $51 3 million, representing 31% growth [87, 88] - The gross margin for 2024 was 84% [87, 88] - The company's revenue guidance for full year 2025 is $55 0 – $58 0 million, with a gross margin of 83% – 84% and operating expenses of $95 0 – $98 0 million [90]

Core Insights - ONWARD Medical N.V. announces changes to its Board of Directors, highlighting the appointment of Professor Tim Denison and the departure of Professor Gregoire Courtine [2][5][7] Company Overview - ONWARD Medical is a leading neurotechnology company focused on developing therapies to restore movement and function in individuals with spinal cord injuries (SCI) and other movement disabilities [10][11] - The company has developed ARC Therapy, which has received 10 Breakthrough Device Designations from the US FDA, and its ARC-EX System is cleared for commercial sale in the US [10] Board Changes - Professor Tim Denison has been appointed to the Board, taking over the seat previously held by Professor Gregoire Courtine, who will continue as Co-Founder and Science Advisor [3][5][8] - Denison brings extensive experience in neurotechnology, having previously served as Vice President of Research & Core Technology at Medtronic and is a co-founder of Amber Therapeutics [4][8] Research and Development Focus - The Neuro-X Institute, directed by Courtine, is a multidisciplinary research hub aimed at accelerating therapies for neurological disorders, while NeuroRestore focuses on recovery therapies for SCI, Parkinson's disease, and stroke [6][10] - ONWARD Medical's commitment to innovation is underscored by its ongoing development of investigational products, including the ARC-IM system [10][18]

Besides celebrating shared bonds, culture and history, the leaders of Britain and France will face the hard grind of, among other things, enhancing Europe’s security—and paying for it https://t.co/PN9T3OgsmZ ...

Your biggest concern at the moment seems to be the appreciation of the euro against the dollar. We were in Sintra earlier this week where the vice president, Mr. . de Guindos, was talking about 120 as the limit.What is your take on this. So I won't comment on my colleagues commands. It's a general rule, but we look closely at the volatility of the exchange rate.It has been significant since the start of the year with a 13% appreciation of the euro against the dollar. By the way, it's not a specific apprecia ...

He says that thimerosal is a neurotoxin that causes neurodevelopmental disorders, notably autism, in children. An American ban on it now seems imminent. The evidence, however, strongly suggests this is a mistake https://t.co/2qQlqCU4a9 ...

The euro cannot quickly supplant the dollar as the anchor of the world’s financial system, European Central Bank Governing Council member Gabriel Makhlouf said https://t.co/vjuI3Uu2WX ...

Danes hug Europe tight as geopolitical challenges loom for the EU https://t.co/vPJLkuPj2u ...

This Affordable European Country Is Launching A Digital Nomad Visa: Here’s What You Need To Know https://t.co/pZ59e2Ikkm ...

The ECB risks undershooting its inflation target if the euro’s strength persists, says Bank of France Governor Francois Villeroy de Galhau https://t.co/okqNfs4SvI https://t.co/CbYvIpQYKp ...